VPH Leadership continues into 2027
We are pleased to present the 2027 Board of Directors of the VPH Society, appointed during the recent GA in Milan to guide the Society’s strategic priorities and initiatives in the year ahead.
Enabling the Digital Revolution of Health
The society for in silico medicine
VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
-
25
Countries involved
-
40+
Institutions involved
-
1000+
Members
-
VPH2026 is approaching!
Do not miss the flagship event of the global in silico medicine community in Milan, 1–4 September 2026.
Registration is open!
Register now
-
What is in silico medicine?
Discover more -
What is the VPH Society?
Discover more -
What do we do?
Discover more
Collaborations
-
-
-
-
News & Events
-
Discover more
-
VPH2026 brings together 650 experts in Milan to advance in silico medicine
A record 650 participants gathered in Milan to exchange knowledge, foster collaboration and explore the future of in silico medicine.
Discover more
-
Meet the new Young Scientists Committee (2027-2028)
During the closing ceremony of its 2026 Conference, VPH announced its largest-ever Young Scientists Committee, which will begin its two-year mandate in January 2027, strengthening opportunities for engagement, support, and representation of early-career researchers.
Discover more
